CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites

Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition.

Guardado en:
Detalles Bibliográficos
Autores principales: Rajeswari Jayavaradhan, Devin M. Pillis, Michael Goodman, Fan Zhang, Yue Zhang, Paul R. Andreassen, Punam Malik
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:af6eb1ef193d4ac7958e34f1c42a6fa1
record_format dspace
spelling oai:doaj.org-article:af6eb1ef193d4ac7958e34f1c42a6fa12021-12-02T14:35:44ZCRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites10.1038/s41467-019-10735-72041-1723https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa12019-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-10735-7https://doaj.org/toc/2041-1723Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition.Rajeswari JayavaradhanDevin M. PillisMichael GoodmanFan ZhangYue ZhangPaul R. AndreassenPunam MalikNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-13 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Rajeswari Jayavaradhan
Devin M. Pillis
Michael Goodman
Fan Zhang
Yue Zhang
Paul R. Andreassen
Punam Malik
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
description Global inhibition of NHEJ factors has been one strategy to improve CRISPR-Cas9 mediated HDR. Here the authors fuse a dominant-negative mutant of 53BP1 to Cas9 to enhance HDR frequency, reduce NHEJ specifically at the Cas9 cut sites, and reduce the toxicity associated with global NHEJ inhibition.
format article
author Rajeswari Jayavaradhan
Devin M. Pillis
Michael Goodman
Fan Zhang
Yue Zhang
Paul R. Andreassen
Punam Malik
author_facet Rajeswari Jayavaradhan
Devin M. Pillis
Michael Goodman
Fan Zhang
Yue Zhang
Paul R. Andreassen
Punam Malik
author_sort Rajeswari Jayavaradhan
title CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
title_short CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
title_full CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
title_fullStr CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
title_full_unstemmed CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
title_sort crispr-cas9 fusion to dominant-negative 53bp1 enhances hdr and inhibits nhej specifically at cas9 target sites
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/af6eb1ef193d4ac7958e34f1c42a6fa1
work_keys_str_mv AT rajeswarijayavaradhan crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT devinmpillis crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT michaelgoodman crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT fanzhang crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT yuezhang crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT paulrandreassen crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
AT punammalik crisprcas9fusiontodominantnegative53bp1enhanceshdrandinhibitsnhejspecificallyatcas9targetsites
_version_ 1718391093671755776